DBCO-PEG4-Val-Cit-PAB-MMAE (CAS: 2129164-91-4) is a specialized compound used in cancer research and the development of antibody-drug conjugates (ADCs) . The DBCO component enables easy connection to biomolecules, while the Val-Cit linker releases the drug once inside cancer cells. This helps kill cancer cells while reducing damage to healthy ones. Ideal for advancing cancer therapies with better targeting and fewer side effects.
Polyethylene Glycol PEG Linkers > Peptide Linkers > Val-Cit Linker
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.